Evidence map›Paper›PMID 28971586›Full record

ArticleMolecular nutrition & food research2018

Dietary N-Glycans from Bovine Lactoferrin and TLR Modulation.

Susana Figueroa-Lozano, Rivca L Valk-Weeber, Sander S van Leeuwen, Lubbert Dijkhuizen, Paul de Vos

Abstract read
In one paragraph

Article in Molecular nutrition & food research, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Article
  6. Review
  7. An overview on in vitro and in vivo antiviral activity of lactoferrin: its efficacy against SARS-CoV-2 infection.Biometals : an international journal on the role of metal ions in biology, biochemistry, and medicine · 2023
    Review
  8. Article
  9. Review
  10. Article
  11. Article
  12. Inhibitory Effects of DietaryFrontiers in immunology · 2020
    Article
  13. Dietary N-Glycans from Bovine Lactoferrin and TLR Modulation.Molecular nutrition & food research · 2018
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Susana Figueroa-LozanoImmunoendocrinology, Division of Medical Biology, Department of Pathology and Medical Biology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.
Rivca L Valk-WeeberMicrobial Physiology, Groningen Biomolecular Sciences and Biotechnology Institute (GBB), Groningen, The Netherlands.
Sander S van LeeuwenMicrobial Physiology, Groningen Biomolecular Sciences and Biotechnology Institute (GBB), Groningen, The Netherlands.
Lubbert DijkhuizenMicrobial Physiology, Groningen Biomolecular Sciences and Biotechnology Institute (GBB), Groningen, The Netherlands.
Paul de VosImmunoendocrinology, Division of Medical Biology, Department of Pathology and Medical Biology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

scopeBovine lactoferrin (bLF) is an ingredient of food supplements and infant formulas given its antimicrobial and antiviral properties. We modified bLF enzymatically to alter its N-glycosylation and to isolate the glycan chains. The aims of this study include (1) to evaluate whether such derivates induce responses via pattern recognition receptors namely Toll-like receptors (TLRs) and (2) to relate those responses to their different glycosylation profiles. METHODS AND

resultsThe unmodified and modified bLF fractions are incubated with reporter cell lines expressing pattern recognition receptors. Afterwards, we screen for TLRs and analyze for nuclear factor kappa-light-chain enhancer of activated B cells (NF-κB) activation. Activation of reporter cell lines show that signaling is highly dependent on TLRs. The activation pattern of bLF is reduced with the desialylated form and increased with the demannosylated form. In reporter cells for TLR, bLF activate TLR-4 and inhibit TLR-3. The isolated glycans from bLF inhibit TLR-8. TLR-2, TLR-5, TLR-7, and TLR-9 are not significantly altered.

conclusionThe profile of glycosylation is key for the biological activity of bLF. By understanding how this affects the human defense responses, the bLF glycan profile can be modified to enhance its immunomodulatory effects when used as a dietary ingredient.

Indexed as

AnimalsCattleCell LineGlycosylationHumansLactoferrinMyeloid Differentiation Factor 88NF-kappa BPolysaccharidesSignal TransductionToll-Like Receptor 3Toll-Like Receptor 4Toll-Like Receptor 8Toll-Like ReceptorsLactoferrinMYD88 protein, humanMyeloid Differentiation Factor 88NF-kappa BPolysaccharidesTLR3 protein, humanTLR4 protein, humanTLR8 protein, humanToll-Like Receptor 3Toll-Like Receptor 4Toll-Like Receptor 8Toll-Like Receptorsbovine lactoferrinNF-κBN-glycosylationtoll-like receptors

Identifiers

PMID28971586
PMCPMC6120133

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.